Skip to Main Content

Author Details

Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
2004
355
42
PMIDPaper TitleJournal TitlePublished Year
37669709Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study.Cancer Res Treat2024
36596730Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group.Cancer Res Treat2023
37958571A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.Int J Mol Sci2023
37900220Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.World J Clin Cases2023
37849818Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.Front Oncol2023
38001733The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.Cancers (Basel)2023
38001620The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.Cancers (Basel)2023
37547446Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.Ther Adv Med Oncol2023
37835414Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.Cancers (Basel)2023
37985381Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.J Breast Cancer2023
37727923Analysis of Prognoses according to Breast MRI Results in Patients with Axillary Lymph Node Metastases from an Unknown Primary Origin.Yonsei Med J2023
37924622Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.Breast2023
37051649Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level.J Breast Cancer2023
36979654Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells.Biomedicines2023
37444546Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.Cancers (Basel)2023
37309655Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.JMIR Public Health Surveill2023
37441323Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.Ann Surg Treat Res2023
37174111Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer.Cancers (Basel)2023
37037826Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.Nat Commun2023
37035212The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMarkâ¿¢) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.Front Oncol2023
37394589Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.Exp Mol Med2023
36854521Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/Src Pathway in HER2-positive Breast Cancer Cells.Anticancer Res2023
36852967Feasibility of Ultrasound-Guided Localization for Clipped Metastatic Axillary Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Pilot Study.J Breast Cancer2023
36689066Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).Breast Cancer2023
36397237Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.Cancer Res Treat2023
36910562The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection.Ann Surg Treat Res2023
36674955Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages.Int J Mol Sci2023
36900347Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.Cancers (Basel)2023
36496488Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?Ann Surg Oncol2023
36496487ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?Ann Surg Oncol2023
33058534Distribution of tumor subtypes in bilateral breast cancer: Comparison between synchronous and metachronous cancer.Asia Pac J Clin Oncol2022
35583693Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis.Ann Surg Oncol2022
35506578Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society.J Breast Cancer2022
35671604Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.Cancer Genet2022
35763158Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy.Breast Cancer Res Treat2022
35454768Measurement of Perfusion Heterogeneity within Tumor Habitats on Magnetic Resonance Imaging and Its Association with Prognosis in Breast Cancer Patients.Cancers (Basel)2022
35621657Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea.Curr Oncol2022
35747813Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.Front Oncol2022
36479604Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.J Breast Cancer2022
36601340Comprehensive clinical characterization of patients with <i>BRCA1</i>: c.5017_5019del germline variant.Ann Surg Treat Res2022
36942579Divorce after breast cancer diagnosis and its impact on quality of life.Palliat Support Care2022
36179501Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy.Breast2022
36362792Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?J Clin Med2022
36031753Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of <i>In Situ</i> Carcinoma.J Breast Cancer2022
36230762Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort.Cancers (Basel)2022
36292113Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer.Diagnostics (Basel)2022
36018520ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis.Ann Surg Oncol2022
35882211Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.Oncology2022
35008143Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience.Cancer Res Treat2022
35034242Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching.Breast Cancer Res Treat2022
  • 1 - 50 of 355

Recommended Authors

Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 3
Fudan University Shanghai Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Qilu Hospital of Shandong University
Career Start Year 2011
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 2
DHC Technologies Co. Ltd.
Career Start Year 2008
Number of shared co-authors 1
University of Milano
Career Start Year 2008
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 3
Nagoya City University Graduate School of Medical Sciences
Career Start Year 2006
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 2
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 3
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year 2003
Number of shared co-authors 0
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 0
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 3
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Universite Libre de Bruxelles
Career Start Year 2000
Number of shared co-authors 0
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year 1998
Number of shared co-authors 2
University of Milan
Career Start Year 1996
Number of shared co-authors 3
University of California
Career Start Year 1996
Number of shared co-authors 0
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 1
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 6
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 2
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 3
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 0
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 14
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 10
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 8
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 3
Seoul National University College of Medicine
Co-authored papers 3
Busan Paik Hospital, Inje University
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Ajou University
Co-authored papers 2
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 2
College of Medicine, The Catholic University of Korea
Co-authored papers 2
Research Institute, National Cancer Center
Co-authored papers 2
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 2
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers 2
University of Chinese Academy of Sciences
Co-authored papers 1
Lerner Research Institute, Cleveland Clinic
Co-authored papers 1
Columbia University
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Netherlands Cancer Institute
Co-authored papers 1
Co-authored papers 1
Inha University
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Seoul National University, College of Medicine
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
University of California Riverside
Co-authored papers 1